Facebook Instagram Twitter Linkedin Youtube Podcast
Solid Biosciences Announces IND Clearance by FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
November 15, 2023
Entrada Therapeutics Announces Updates on ENTR-601-44 in Duchenne Muscular Dystrophy
November 27, 2023

Astellas Study Results Available for ASP0367 (MA-0211) in Pediatric Male Patients with Duchenne Muscular Dystrophy

November 16, 2023

On November 15, 2023, Astellas Pharma shared a community letter with information on obtaining results for ASP0367 (MA-0211) in Pediatric Male patients with Duchenne muscular dystrophy.

Astellas’ Community Letter can be found by clicking here.

Astellas’ clinical trial study details can be found on their website.

Jett Foundation, Inc.
65 Cordage Park Circle
Suite 130 | Plymouth, MA 02360
781-585-5566 | info@jettfoundation.org

Gold Transparency 2022 Candid. Logo
Sitemap
© 2023 All rights reserved. Powered by Getfused

Support Jett Foundation

Donate Today
Jett Foundation, Inc. is a 501(c)3 registered tax-exempt nonprofit organization. Our Federal Tax ID is 04-3563445.

Stay Connected With Us

Sign up to receive our newsletter and updates.
Required fields are denoted with an asterisk (*)





    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Accessible Vehicle Fund Applications Open

    Apply Today